Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Pediatrics/Neonatology | Hematology | Family Medicine

Kawasaki Disease Clinical Trials

A listing of Kawasaki Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


New York

Montefiore Medical Center
Bronx New York 10467
Updated

Patients are needed to participate in a clinical research study evaluating Etanercept and Placebo for the treatment of Mucocutaneous Lymph Node Syndrome or Kawasaki Disease

Columbia University Medical Center
New York New York 10032
Updated

Patients are needed to participate in a clinical research study evaluating Etanercept and Placebo for the treatment of Mucocutaneous Lymph Node Syndrome or Kawasaki Disease

Texas

Texas Children's Hospital
Houston Texas 77030
Updated

Patients are needed to participate in a clinical research study evaluating Etanercept and Placebo for the treatment of Mucocutaneous Lymph Node Syndrome or Kawasaki Disease

Washington

Seattle Children's Hospital
Seattle Washington 98105
Updated

Patients are needed to participate in a clinical research study evaluating Etanercept and Placebo for the treatment of Mucocutaneous Lymph Node Syndrome or Kawasaki Disease

Canada

Sainte-Justine Hospital
Montreal Quebec H3T 1C5
Updated

Patients are needed to participate in a clinical research study evaluating Etanercept and Placebo for the treatment of Mucocutaneous Lymph Node Syndrome or Kawasaki Disease

Japan

Investigational site
Chubu

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Chugoku

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Hokkaido

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Kanto

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Kyushu

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

View More »

Investigational site
Shinetu

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Tohoku

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Investigational site
Tokai

Patients are needed to participate in a clinical research study evaluating TA-650 and Polyethylene Glycol-treated Human Immunoglobulin (VGIH) for the treatment of Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin